Donner la Frousse au Cancer is a year-round campaign to raise funds for the CHUM radio-oncology department.
Drs. Delouya and Roberge, both familiar with fundraising, wanted to give back to their patients. So they decided to partner with the Institut du cancer de Montréal and organize an activity to bring together patients, families, and CHUM radio-oncology employees. And so “Donner la Frousse au Cancer” - that can be translated to Give Cancer a Scare - was born.
The event aims to support the CHUM radio-oncology department by:
Financing the improvement and personalization of patient care
Supporting research in radio-oncology.
The CHUM radio-oncology team, led by Dr. David Roberge, is a multidisciplinary team composed of research clinicians and fundamental researchers from the radiology department who are active in the Institut du cancer de Montréal. The radio-oncology research team performs high quality studies in multiple areas of oncology (breast, prostate, brain cancer, etc.).
Did you know that over half of all patients diagnosed with cancer receive radiotherapy?
Radiotherapy is an extremely versatile form of treatment. For some types of cancer, radiotherapy alone will destroy the tumour. In other cases, we use radiotherapy in concert with other approaches such as chemotherapy, hormone therapy, and surgery. Sometimes radiotherapy is used to reduce tumour size before surgery, or to ensure that cancerous cells can’t multiply again after surgery. Radiotherapy can also be used to reduce pain, bleeding, and other symptoms of cancer.
Recent advances in technology allow us to conduct in depth studies to better understand why and how radiotherapy works, as well as who will benefit most from radiotherapy, all while attempting to limit side effects as much as possible.
Thanks to your generous donations, since 2014 we have raised $216,968 net for cancer research which has been distributed as scholarships for research projects in radio-oncology. Multiple radiotherapy projects have been funded, in both fundamental research to clinical research. These projects included prostate cancer, uterine cancer and lung cancer.
This event would not be possible without our generous donors. Through their support, they allow us to offer the best care possible to our patients.